DOI:

10.37988/1811-153X_2023_1_74

Postcovid distant complications in periodontal tissues in individuals after inpatient treatment in the red zone

Downloads

Authors

  • A.A. Remizova 1, PhD in Medical Sciences, associate professor and head of the Dentistry Department No. 3
    ORCID: 0000-0001-5951-9454
  • Yu.I. Tin'gaeva 1, postgraduate at the Dentistry Department No. 3
    ORCID: 0000-0001-8471-0146
  • M.G. Dzgoeva 1, PhD in Medical Sciences, associate professor and head of the Dentistry Department No. 3
    ORCID: 0000-0002-0247-1901
  • R.B. Yakubov 1, PhD in Medical Sciences, associate professor of the Dentistry Department No. 2
    ORCID: 0000-0002-9149-6317
  • N.O. Remizov 2, 1st year student at the Dental Faculty
    ORCID: 0000-0002-7596-0618
  • 1 North Ossetian State Medical Academy, 362019, Vladikavkaz, Russia
  • 2 Moscow State University of Medicine and Dentistry, 127473, Moscow, Russia

Abstract

There are no data in the literature on long-term complications in periodontal tissues due to a coronavirus infection. The aim is to study postcovid complications arising in periodontal tissues in patients with general somatic pathology. >. At the first stage, 296 patients were examined who were treated in hospitals for COVID-19 and 128 people — the comparison group — without concomitant pathology, who were divided into 6 age groups. The examination included measuring the microcirculation index (MI) and determining the degree of oxygenation in periodontal tissues according to Laser Doppler Flowmetry (LDF) data. At the second stage, the same indicators were determined in 74 patients with complications after COVID-19 in the form of periodontitis, and an index evaluation of periodontal tissues was also performed: periodontal index (PI). The severity of periodontal pathology and the period of its occurrence were assessed depending on the age of patients, the effect of postcovid vasculitis on the state of the microcirculatory bed and the nature of the course of pathological processes in the periodontal. Dopplerograms revealed predictors of the development of severe periodontal pathology. >. The integral microcirculation index and the level of oxygenation in the periodontium and on the phalanx of the finger in patients with COVID-19 undergoing inpatient treatment were statistically significantly lower than in patients of control groups. Against the background of improved microcirculation and oxygenation of periodontal tissues by 3 months after coronavirus infection, there is a decrease in PMA and PI indices. By the 6th and even more than the 9th month, the examined patients showed a drop in the indicators of regional blood flow and the level of tissue saturation against the background of an increase in the indices of PMA and PI. >. The greatest number of pathological processes in periodontal tissues occurred in the period from 6 to 9 months, the most pronounced in the age group of 65—80 years — 43.1%, 55—64 years — 41.3%, 45—54 years — in 31.3% of patients. In patients with severe hemorrhagic vasculitis (1.1%), the most pronounced changes in periodontal tissues were observed. In this category of patients, 3 months after the infection, there was a sharp development of rapidly progressive periodontopathy, and by the 9th month there was a complete loss of teeth. The severe form of hemorrhagic vasculitis was characterized by severe microcirculation disorders in periodontal tissues (PM=16.1±0.9).The indicators of microcirculation (PM) below 17.1 and hemoglobin oxygen saturation (SO2) below 77.9 are predictors of the development of inflammatory changes in periodontal tissues.

Key words:

post-COVID complications, vasculitis, COVID-19, clinical symptoms, dental status

For Citation

[1]
Remizova A.A., Tin’gaeva Yu.I., Dzgoeva M.G., Yakubov R.B., Remizov N.O. Postcovid distant complications in periodontal tissues in individuals after inpatient treatment in the red zone. Clinical Dentistry (Russia).  2023; 26 (1): 74—82. DOI: 10.37988/1811-153X_2023_1_74

References

  1. Anaev E.Kh., Knyazheskaya N.P. Coagulopathy in COVID-19: Focus on anticoagulant therapy. Practical pulmonology. 2020; 1: 3—13 (In Russ.). eLIBRARY ID: 43863883
  2. Namitokov A.M., Ishevskaya O.P., Fetisova V.I., Kosmacheva E.D., Porkhanov V.A. Diagnosis and treatment of acute coronary syndrome during the novel coronavirus infection COVID-19 pandemic. Russian Journal of Cardiology. 2020; 4: 86—94 (In Russ.). eLIBRARY ID: 42818937
  3. Remizova A.A., Dzgoeva M.G., Tingaeva Yu.I., Khubulov S.A., Gutnov V.M., Bitarov P.A., Tserekova A.A. Tissue dental status and features of periodontal microcirculation in patients with new coronavirus infection COVID-19. Pharmacophore. 2021; 12 (2): 6—13. DOI: 10.51847/5JIbnUbHkT
  4. Bhujel N., Zaheer K., Singh R.P. Oral mucosal lesions in patients with COVID-19: a systematic review. Br J Oral Maxillofac Surg. 2021; 59 (9): 1024—1030. PMID: 34563354
  5. Zamechnik T.V., Rogova L.N. Hypoxia as starting factor of development of endothelial dysfunction and inflammation of the vascular wall (literature review). Journal of New Medical Technologies. 2012; 2: 393—394 (In Russ.). eLIBRARY ID: 17879029
  6. Petrikov S.S., Ivannikov A.A., Vasilchenko M.K., Esaulenko A.N., Alidzhanova K.G. COVID-19 and cardiovascular system. Part 1. Pathophysiology, pathomorphology, complications, long-term prognosis. Russian Sklifosovsky Journal of Emergency Medical Care. 2021; 1: 14—26 (In Russ.). eLIBRARY ID: 45479075
  7. Fantozzi P.J., Pampena E., Di Vanna D., Pellegrino E., Corbi D., Mammucari S., Alessi F., Pampena R., Bertazzoni G., Minisola S., Mastroianni C.M., Polimeni A., Romeo U., Villa A. Xerostomia, gustatory and olfactory dysfunctions in patients with COVID-19. Am J Otolaryngol. 2020; 41 (6): 102721. PMID: 32977063
  8. Karyakin N.N., Kostina O.V., Galova E.A., Popovicheva A.N., Sosnina L.N., Presnyakova M.V., Makarova E.V., Tulichev A.A. Disorders of the erythrocytes rheological properties in patients with COVID-19. Medical Almanac. 2020; 3 (64): 52—56 (In Russ.). eLIBRARY ID: 44018585
  9. Nikiforov V.V., Suranova T.G., Chernobrovkina T.Ya., Yankovskaya Y.D., Burova S.V. New coronavirus infection (Covid-19): Clinical and epidemiological aspects. The Russian Archives of Internal Medicine. 2020; 2 (52): 87—93 (In Russ.). eLIBRARY ID: 42620165
  10. Grigoryeva N.Yu., Tarlovskaya E.I. Management strategies of patients with acute coronary syndrome during COVID-19 pandemic. Medical Almanac. 2020; 2 (63): 49—57 (In Russ.). eLIBRARY ID: 43118604
  11. Farid H., Khan M., Jamal S., Ghafoor R. Oral manifestations of Covid-19 A literature review. Rev Med Virol. 2022; 32 (1): e2248. PMID: 34028129
  12. Perico L., Benigni A., Remuzzi G. Should COVID-19 concern nephrologists? Why and to what extent? The emerging impasse of angiotensin blockade. Nephron. 2020; 144 (5): 213—221. PMID: 32203970
  13. Larina V.N., Golovko M.G., Larin V.G. Possible effects of coronavurus infection (COVID-19) on the cardiovascular system. Bulletin of Russian State Medical University. 2020; 2: 5—13. DOI: 10.24075/brsmu.2020.020
  14. Makedonova Yu.A., Poroisky S.V., Gavrikova L.M., Afanaseva O.Y.Manifestat ion of the oral mucosa diseases in patients with COVID-19. Vestnik VSMU. 2021; 1 (77): 110—115 (In Russ.). eLIBRARY ID: 45153499
  15. Khabadze Z.S., Sobolev K.E., Todua I.M., Mordanov O.S. Changes in the oral mucosa and general indicators with COVID 19 (SARS-CoV-2): a single-center descriptive study. Endodontics Today. 2020; 2: 4—9 (In Russ.). eLIBRARY ID: 43326778
  16. Thachil J., Tang N., Gando S., Falanga A., Cattaneo M., Levi M., Clark C., Iba T. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J ThrombHaemost. 2020; 18 (5): 1023—1026. PMID: 32338827
  17. Gando S., Levi M., Toh C.H. Disseminated intravascular coagulation. Nat Rev Dis Primers. 2016; 2: 16037. PMID: 27250996
  18. Smeda M., Chlopicki S. Endothelial barrier integrity in COVID-19-dependent hyperinflammation: does the protective facet of platelet function matter? Cardiovasc Res. 2020; 116 (10): e118-e121. PMID: 32707576
  19. Yavelov I.S., Drapkina O.M. Covid-19: hemostatic parameters and specifics of antithrombotic treatment. Cardiovascular Therapy and Prevention . 2020; 3: 310—318 (In Russ.). eLIBRARY ID: 43050198
  20. Xydakis M.S., Dehgani-Mobaraki P., Holbrook E.H., Geisthoff U.W., Bauer C., Hautefort C., Herman P., Manley G.T., Lyon D.M., Hopkins C. Smell and taste dysfunction in patients with COVID-19. Lancet Infect Dis. 2020; 20 (9): 1015—1016. PMID: 32304629
  21. Brandão T.B., Gueiros L.A., Melo T.S., Prado-Ribeiro A.C., Nesrallah A.C.F.A., Prado G.V.B., Santos-Silva A.R., Migliorati C.A. Oral lesions in patients with SARS-CoV-2 infection: could the oral cavity be a target organ? Oral Surg Oral Med Oral Pathol Oral Radiol. 2021; 131 (2): e45-e51. PMID: 32888876
  22. Hendren N.S., Drazner M.H., Bozkurt B., Cooper L.T. Jr Description and proposed management of the acute COVID-19 cardiovascular syndrome. Circulation. 2020; 141 (23): 1903—1914. PMID: 32297796
  23. Nouchi A., Chastang J., Miyara M., Lejeune J., Soares A., Ibanez G., Saadoun D., Morélot-Panzini C., Similowski T., Amoura Z., Boddaert J., Caumes E., Bleibtreu A., Lorenzo A., Tubach F., Pourcher V. Prevalence of hyposmia and hypogeusia in 390 COVID-19 hospitalized patients and outpatients: a cross-sectional study. Eur J Clin Microbiol Infect Dis. 2021; 40 (4): 691—697. PMID: 33033955
  24. Wang J., Hajizadeh N., Moore E.E., McIntyre R.C., Moore P.K., Veress L.A., Yaffe M.B., Moore H.B., Barrett C.D. Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series. J ThrombHaemost. 2020; 18 (7): 1752—1755. PMID: 32267998

Downloads

Received

December 6, 2022

Accepted

January 20, 2023

Published on

March 22, 2023